{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T06:25:23Z","timestamp":1776752723121,"version":"3.51.2"},"reference-count":32,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2015,12,1]],"date-time":"2015-12-01T00:00:00Z","timestamp":1448928000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Preventive Medicine"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1016\/j.ypmed.2015.10.007","type":"journal-article","created":{"date-parts":[[2015,10,26]],"date-time":"2015-10-26T17:08:34Z","timestamp":1445879314000},"page":"405-411","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":35,"special_numbering":"C","title":["Providers' beliefs about the effectiveness of the HPV vaccine in preventing cancer and their recommended age groups for vaccination: Findings from a provider survey, 2012"],"prefix":"10.1016","volume":"81","author":[{"given":"Z.","family":"Berkowitz","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Malone","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Rodriguez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4527-828X","authenticated-orcid":false,"given":"M.","family":"Saraiya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ypmed.2015.10.007_bb0005","author":"American Academy of Pediatrics"},{"key":"10.1016\/j.ypmed.2015.10.007_bb0010","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1080\/21645515.2015.1022691","article-title":"A brief educational intervention increases providers' human papillomavirus vaccine knowledge","volume":"11","author":"Berenson","year":"2015","journal-title":"Hum. Vaccin. immunotherapeutics"},{"key":"10.1016\/j.ypmed.2015.10.007_bb0015","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1097\/OLQ.0b013e3181f12dbf","article-title":"Longitudinal predictors of human papillomavirus vaccine initiation among adolescent girls in a high-risk geographic area","volume":"38","author":"Brewer","year":"2011","journal-title":"Sex. Transm. Dis."},{"key":"10.1016\/j.ypmed.2015.10.007_bb0020","first-page":"1705","article-title":"Recommendations on the use of quadrivalent human papillomavirus vaccine in males\u2014Advisory Committee on Immunization Practices (ACIP), 2011","volume":"60","author":"Centers for Disease Control and Prevention","year":"2011","journal-title":"MMWR Morb. Mortal. Wkly Rep."},{"key":"10.1016\/j.ypmed.2015.10.007_bb0025","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1097\/01.AOG.0000444458.00612.6b","article-title":"Committee opinion no. 588: human papillomavirus vaccination","volume":"123","author":"Committee on Adolescent Health Care of the American College of Obstetricians and Gynecologists","year":"2014","journal-title":"Obstet. Gynecol."},{"key":"10.1016\/j.ypmed.2015.10.007_bb0030","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1542\/peds.2011-3865","article-title":"HPV vaccine recommendations","volume":"129","author":"Committee on Infectious Diseases","year":"2012","journal-title":"Pediatrics"},{"key":"10.1016\/j.ypmed.2015.10.007_bb0035","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1542\/peds.2009-3500","article-title":"Human papillomavirus vaccination practices: a survey of US physicians 18months after licensure","volume":"126","author":"Daley","year":"2010","journal-title":"Pediatrics"},{"key":"10.1016\/j.ypmed.2015.10.007_bb0040","first-page":"69","article-title":"CDC grand rounds: reducing the burden of HPV-associated cancer and disease","volume":"63","author":"Dunne","year":"2014","journal-title":"MMWR Morb. Mortal. Wkly Rep."},{"key":"10.1016\/j.ypmed.2015.10.007_bb0045","first-page":"625","article-title":"National, regional, state, and selected local area vaccination coverage among adolescents aged 13\u201317years\u2014United States, 2013","volume":"63","author":"Elam-Evans","year":"2014","journal-title":"MMWR Morb. Mortal. Wkly Rep."},{"key":"10.1016\/j.ypmed.2015.10.007_bb0050","doi-asserted-by":"crossref","first-page":"2627","DOI":"10.4161\/hv.25823","article-title":"Impact of a physician recommendation and parental immunization attitudes on receipt or intention to receive adolescent vaccines","volume":"9","author":"Gargano","year":"2013","journal-title":"Hum. Vaccin. immunotherapeutics"},{"key":"10.1016\/j.ypmed.2015.10.007_bb0055","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1056\/NEJMoa0909537","article-title":"Efficacy of quadrivalent HPV vaccine against HPV Infection and disease in males","volume":"364","author":"Giuliano","year":"2011","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ypmed.2015.10.007_bb0060","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0068329","article-title":"Reduced prevalence of oral human papillomavirus (HPV) 4years after bivalent HPV vaccination in a randomized clinical trial in Costa Rica","volume":"8","author":"Herrero","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.ypmed.2015.10.007_bb0065","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1056\/NEJMoa1405044","article-title":"A 9-valent HPV vaccine against infection and intraepithelial neoplasia in women","volume":"372","author":"Joura","year":"2015","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ypmed.2015.10.007_bb0070","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1016\/j.jadohealth.2005.07.014","article-title":"Pediatricians' intention to administer human papillomavirus vaccine: the role of practice characteristics, knowledge, and attitudes","volume":"37","author":"Kahn","year":"2005","journal-title":"J. Adolesc. Health : Off. Publ. Soc. Adolesc. Med."},{"key":"10.1016\/j.ypmed.2015.10.007_bb0075","doi-asserted-by":"crossref","first-page":"3112","DOI":"10.1016\/j.vaccine.2012.02.034","article-title":"Factors associated with human papillomavirus vaccine-series initiation and healthcare provider recommendation in US adolescent females: 2007 National Survey of Children's Health","volume":"30","author":"Lau","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.ypmed.2015.10.007_bb0085","series-title":"MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports \/ Centers for Disease Control and prevention","first-page":"1","article-title":"Quadrivalent human papillomavirus vaccine: recommendations of the advisory committee on immunization practices (ACIP)","volume":"56","author":"Markowitz","year":"2007"},{"key":"10.1016\/j.ypmed.2015.10.007_bb0080","series-title":"MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports \/ Centers for Disease Control","first-page":"1","article-title":"Human papillomavirus vaccination: recommendations of the Advisory Committee on Immunization Practices (ACIP)","volume":"63","author":"Markowitz","year":"2014"},{"key":"10.1016\/j.ypmed.2015.10.007_bb0090","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/j.pedhc.2014.05.003","article-title":"HPV vaccine hesitancy: findings from a statewide survey of health care providers","volume":"28","author":"McRee","year":"2014","journal-title":"J. Pediatr. Health Care : Off. Public. Natl. Assoc. Pediatr. Nurs. Associates Practitioners"},{"key":"10.1016\/j.ypmed.2015.10.007_bb0095","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.1056\/NEJMoa1010971","article-title":"HPV vaccine against anal HPV infection and anal intraepithelial neoplasia","volume":"365","author":"Palefsky","year":"2011","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ypmed.2015.10.007_bb0100","series-title":"Women's health issues : official publication of the Jacobs Institute of Women's Health","first-page":"97","article-title":"Why are U.S. girls getting meningococcal but not human papilloma virus vaccines? Comparison of factors associated with human papilloma virus and meningococcal vaccination among adolescent girls 2008 to 2012","volume":"25","author":"Perkins","year":"2015"},{"key":"10.1016\/j.ypmed.2015.10.007_bb0105","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/j.vaccine.2014.12.021","article-title":"Age at HPV vaccine initiation and completion among US adolescent girls: trend from 2008 to 2012","volume":"33","author":"Rahman","year":"2015","journal-title":"Vaccine"},{"key":"10.1016\/j.ypmed.2015.10.007_bb0110","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1001\/archpedi.161.3.252","article-title":"National health care visit patterns of adolescents: implications for delivery of new adolescent vaccines","volume":"161","author":"Rand","year":"2007","journal-title":"Arch. Pediatr. Adolesc. Med."},{"key":"10.1016\/j.ypmed.2015.10.007_bb0115","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/j.socscimed.2009.05.024","article-title":"Parents' health beliefs and HPV vaccination of their adolescent daughters","volume":"69","author":"Reiter","year":"2009","journal-title":"Soc. Sci. Med."},{"key":"10.1016\/j.ypmed.2015.10.007_bb0120","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1016\/j.vaccine.2009.12.063","article-title":"Predictors of HPV vaccine uptake among women aged 19\u201326: importance of a physician's recommendation","volume":"29","author":"Rosenthal","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.ypmed.2015.10.007_bb0125","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1089\/jwh.2011.3313","article-title":"Cancers that U.S. physicians believe the HPV vaccine prevents: findings from a physician survey, 2009","volume":"21","author":"Saraiya","year":"2012","journal-title":"J. Women's Health"},{"key":"10.1016\/j.ypmed.2015.10.007_bb0130","doi-asserted-by":"crossref","DOI":"10.1093\/jnci\/djv086","article-title":"US assessment of HPV types in cancers: implications for current and 9-valent HPV vaccines","volume":"107","author":"Saraiya","year":"2015","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.ypmed.2015.10.007_bb0135","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1001\/jama.2015.6041","article-title":"State vaccination requirements for HPV and other vaccines for adolescents, 1990\u20132015","volume":"314","author":"Schwartz","year":"2015","journal-title":"JAMA"},{"key":"10.1016\/j.ypmed.2015.10.007_bb0140","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.jadohealth.2011.11.004","article-title":"Four-year follow-up of the immunogenicity and safety of the HPV-16\/18 AS04-adjuvanted vaccine when administered to adolescent girls aged 10\u201314years","volume":"50","author":"Schwarz","year":"2012","journal-title":"J. Adolesc. Health : Off. Publ. Soc. Adolesc. Med."},{"issue":"Suppl. 10","key":"10.1016\/j.ypmed.2015.10.007_bb0145","doi-asserted-by":"crossref","first-page":"K68","DOI":"10.1016\/j.vaccine.2008.05.065","article-title":"Early experience with human papillomavirus vaccine introduction in the United States, Canada and Australia","volume":"26","author":"Shefer","year":"2008","journal-title":"Vaccine"},{"key":"10.1016\/j.ypmed.2015.10.007_bb0150","series-title":"Accelerating HPV Vaccine Uptake: Urgency for Action to Prevent Cancer","author":"The president cancer panel","year":"2014"},{"key":"10.1016\/j.ypmed.2015.10.007_bb0155","first-page":"95","article-title":"Vaccination coverage among adults, excluding influenza vaccination\u2014United States, 2013","volume":"64","author":"Williams","year":"2015","journal-title":"MMWR Morb. Mortal. Wkly Rep."},{"key":"10.1016\/j.ypmed.2015.10.007_bb0160","doi-asserted-by":"crossref","first-page":"164","DOI":"10.2105\/AJPH.2011.300600","article-title":"Health care provider recommendation, human papillomavirus vaccination, and race\/ethnicity in the US National Immunization Survey","volume":"103","author":"Ylitalo","year":"2013","journal-title":"Am. J. Public Health"}],"container-title":["Preventive Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091743515003199?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091743515003199?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,18]],"date-time":"2018-09-18T03:50:20Z","timestamp":1537242620000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0091743515003199"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,12]]},"references-count":32,"alternative-id":["S0091743515003199"],"URL":"https:\/\/doi.org\/10.1016\/j.ypmed.2015.10.007","relation":{},"ISSN":["0091-7435"],"issn-type":[{"value":"0091-7435","type":"print"}],"subject":[],"published":{"date-parts":[[2015,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Providers' beliefs about the effectiveness of the HPV vaccine in preventing cancer and their recommended age groups for vaccination: Findings from a provider survey, 2012","name":"articletitle","label":"Article Title"},{"value":"Preventive Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ypmed.2015.10.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}